These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 3053811)

  • 1. Recognition of malignant melanoma by monoclonal antibody HMB-45. An immunohistochemical study of 200 paraffin-embedded cutaneous tumors.
    Wick MR; Swanson PE; Rocamora A
    J Cutan Pathol; 1988 Aug; 15(4):201-7. PubMed ID: 3053811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SM5-1: a new monoclonal antibody which is highly sensitive and specific for melanocytic lesions.
    Trefzer U; Rietz N; Chen Y; Audring H; Herberth G; Siegel P; Reinke S; Königer P; Wu S; Ma J; Liu Y; Wang H; Sterry W; Guo Y
    Arch Dermatol Res; 2000 Dec; 292(12):583-9. PubMed ID: 11214818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical diagnosis of malignant melanoma of the conjunctiva and uvea: comparison of the novel antibody against melan-A with S100 protein and HMB-45.
    Heegaard S; Jensen OA; Prause JU
    Melanoma Res; 2000 Aug; 10(4):350-4. PubMed ID: 10985669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary mucosal malignant melanoma: an immunohistochemical study of 12 cases with comparison to cutaneous and metastatic melanomas.
    Fitzgibbons PL; Chaurushiya PS; Nichols PW; Chandrasoma PT; Martin SE
    Hum Pathol; 1989 Mar; 20(3):269-72. PubMed ID: 2722176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance, specificity, and ultrastructural localization of HMB-45 antigen in pigmented ocular tumors.
    Steuhl KP; Rohrbach JM; Knorr M; Thiel HJ
    Ophthalmology; 1993 Feb; 100(2):208-15. PubMed ID: 8437829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative distribution of S-100 protein and antigen HMB-45 in various types of melanomas and naevi.
    Mirecka J; Korabiowska M; Schauer A
    Pol J Pathol; 1995; 46(3):167-72. PubMed ID: 7496736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanoma cell heterogeneity. A study of two monoclonal antibodies compared with S-100 protein in paraffin sections.
    Duray PH; Palazzo J; Gown AM; Ohuchi N
    Cancer; 1988 Jun; 61(12):2460-8. PubMed ID: 3365669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical analysis of cutaneous malignant melanoma: comparison of S-100 protein, HMB-45 monoclonal antibody and NKI/C3 monoclonal antibody.
    Fernando SS; Johnson S; Bäte J
    Pathology; 1994 Jan; 26(1):16-9. PubMed ID: 8165017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical expression of S-100 beta in choroidal melanomas.
    Martins MC; Scull JJ; Alcocer CE; Deschênes J; Antecka E; Burnier MN
    Can J Ophthalmol; 1997 Oct; 32(6):378-81. PubMed ID: 9363341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of immunohistochemical labelling of melanocyte differentiation antibodies melan-A, tyrosinase and HMB 45 with NKIC3 and S100 protein in the evaluation of benign naevi and malignant melanoma.
    Orchard GE
    Histochem J; 2000 Aug; 32(8):475-81. PubMed ID: 11095072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical study of melanocytic differentiation antigens in cutaneous malignant melanoma. A comparison of six commercial antibodies and one non-commercial antibody in nodular melanoma, superficially spreading melanoma and lentigo maligna melanoma.
    Kocan P; Jurkovic I; Böör A; Dudríková K; Krajcár R; Benický M; Kromydaki A
    Cesk Patol; 2004 Apr; 40(2):50-6. PubMed ID: 15233017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMB-45 detection in adenocarcinomas.
    Hancock C; Allen BC; Herrera GA
    Arch Pathol Lab Med; 1991 Sep; 115(9):886-90. PubMed ID: 1718237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reactivity of five different antibodies with benign and malignant melanocytic lesions].
    Plótár V; Szentirmay Z; Orosz Z
    Magy Onkol; 2008 Dec; 52(4):363-73. PubMed ID: 19068464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of HMB-45 monoclonal antibody and S-100 protein in the immunohistochemical diagnosis of melanoma.
    Ordóñez NG; Ji XL; Hickey RC
    Am J Clin Pathol; 1988 Oct; 90(4):385-90. PubMed ID: 2459952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of immunohistochemical staining of the novel antibody melan-A with S100 protein and HMB-45 in malignant melanoma and melanoma variants.
    Blessing K; Sanders DS; Grant JJ
    Histopathology; 1998 Feb; 32(2):139-46. PubMed ID: 9543670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical detection of melanoma-specific antigens in spontaneous canine melanoma.
    Sulaimon S; Kitchell B; Ehrhart E
    J Comp Pathol; 2002; 127(2-3):162-8. PubMed ID: 12354527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical evaluation of uveal melanocytic tumors. Expression of HMB-45, S-100 protein, and neuron-specific enolase.
    Burnier MN; McLean IW; Gamel JW
    Cancer; 1991 Aug; 68(4):809-14. PubMed ID: 1855181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial markers in malignant melanoma. A study of primary lesions and their metastases.
    Ben-Izhak O; Stark P; Levy R; Bergman R; Lichtig C
    Am J Dermatopathol; 1994 Jun; 16(3):241-6. PubMed ID: 7524376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMB-45 staining in benign and malignant melanocytic lesions. A reflection of cellular activation.
    Skelton HG; Smith KJ; Barrett TL; Lupton GP; Graham JH
    Am J Dermatopathol; 1991 Dec; 13(6):543-50. PubMed ID: 1725245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microphthalmia transcription factor: a sensitive and specific marker for malignant melanoma in cytologic specimens.
    Dorvault CC; Weilbaecher KN; Yee H; Fisher DE; Chiriboga LA; Xu Y; Chhieng DC
    Cancer; 2001 Oct; 93(5):337-43. PubMed ID: 11668469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.